FDA Approved: VAGIFEM — Supplemental Application (Novo Nordisk)

View source ↗

Summary

The FDA approved a supplemental application for Vagifem (estradiol) from Novo Nordisk, indicating updated labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genitourinary Syndrome of Menopause
• Vulvar and Vaginal Atrophy

Drugs mentioned

• Vagifem (Estradiol)

Snippet

SUPPL AP for VAGIFEM (ESTRADIOL)